Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the month of January 2021, with a specific reporting date of January 15, 2021. The document serves as a transaction notification regarding share acquisitions by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) with them.
Key Financial Metrics
The filing does not provide corporate-level financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details specific share transactions executed on the London Stock Exchange (XLON).
| Transaction Date | Instrument | Price per Share | Total Volume | Transaction Type |
|---|---|---|---|---|
| January 14, 2021 | Ordinary Shares (25p each) | £13.8802 | 1,645 shares | Acquisition via Dividend Re-investment |
Note: The total volume of 1,645 shares is the aggregate of six individual transactions listed in the filing.
Material Changes
The filing does not report material changes to the company's financial position, operations, or strategy compared to prior periods. It strictly documents routine compliance disclosures for share acquisitions resulting from dividend re-investment plans.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a statutory disclosure of insider trading activity.
Investor Verification Points
- Transaction Nature: Verify that all listed share acquisitions were executed solely through the re-investment of dividends paid on January 14, 2021, rather than open market purchases.
- Participants: Confirm the identities of the PDMRs and PCAs involved, including Mr. N Hirons, Ms. S Jackson, Mr. D Jackson, Ms. V Whyte, Mr. I Whyte, and Ms. D Connor.
- Share Price Consistency: Note that all transactions occurred at a uniform price of £13.8802 per share on the London Stock Exchange.
- Volume Discrepancies: Review the specific share volumes per individual, ranging from 1 share (Mr. D Jackson) to 1,052 shares (Mr. I Whyte).